Cut-off value of FEV1/FEV6 to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Postbronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) less than 0.7 using spirometry is the golden standard to diagnose airf low limitation of chronic obstructive pulmonary disease (COPD). Recently, measuring FEV6 has been suggested as an alternative to measure FVC. Studies about the cut-off value for FEV1/FEV6 to diagnose airflow limitation have shown variable results, with values between 0.7 and 0.8. The purpose of this study was to determine the best cut-off value of FEV1/FEV6 to detect airflow limitation using handheld spirometry. Methods: We recruited subjects over 40 years of age with smoking history over 10 pack-years. Participants underwent measurements with both handheld spirometry and conventional spirometry. We calculated the sensitivity and specificity of the value of FEV1/FEV6 using receiver-operating characteristic (ROC) curve analysis to obtain the diagnostic accuracy of handheld spirometry to detect airflow limitation. Results: A total of 290 subjects were enrolled. Their mean age and smoking amount were 63.1 years and 31.6 pack-years, respectively. According to our ROC curve analysis, when FEV1/FEV6 ratio was 73%, sensitivity and specificity were the maximum and the area under the ROC curve was 0.93, showing an excellent diagnostic accuracy. Sensitivity, specificity, positive predictive value, and negative predictive value were 86.7%, 89.7%, 88.0%, and 88.5%, respectively. Participants with FEV1/FEV6 ≤ 73% had lower FEV1 predicted value compared to those with FEV1/FEV6 > 73% (65.4% vs. 86.5%, p < 0.001). Conclusions: In summary, we demonstrate that the value of 73% in FEV1/FEV6 using handheld spirometry has the best sensitivity and specificity to detect airflow limitation in subjects with risk of COPD.
Abstract
Background/Aims: Postbronchodilator forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) less than 0.7 using spirometry is the golden standard to diagnose airf low limitation of chronic obstructive pulmonary disease (COPD). Recently, measuring FEV6 has been suggested as an alternative to measure FVC. Studies about the cut-off value for FEV1/FEV6 to diagnose airflow limitation have shown variable results, with values between 0.7 and 0.8. The purpose of this study was to determine the best cut-off value of FEV1/FEV6 to detect airflow limitation using handheld spirometry. Methods: We recruited subjects over 40 years of age with smoking history over 10 pack-years. Participants underwent measurements with both handheld spirometry and conventional spirometry. We calculated the sensitivity and specificity of the value of FEV1/FEV6 using receiver-operating characteristic (ROC) curve analysis to obtain the diagnostic accuracy of handheld spirometry to detect airflow limitation. Results: A total of 290 subjects were enrolled. Their mean age and smoking amount were 63.1 years and 31.6 pack-years, respectively. According to our ROC curve analysis, when FEV1/FEV6 ratio was 73%, sensitivity and specificity were the maximum and the area under the ROC curve was 0.93, showing an excellent diagnostic accuracy. Sensitivity, specificity, positive predictive value, and negative predictive value were 86.7%, 89.7%, 88.0%, and 88.5%, respectively. Participants with FEV1/FEV6 ≤ 73% had lower FEV1 predicted value compared to those with FEV1/FEV6 > 73% (65.4% vs. 86.5%, p < 0.001). Conclusions: In summary, we demonstrate that the value of 73% in FEV1/FEV6 using handheld spirometry has the best sensitivity and specificity to detect airflow limitation in subjects with risk of COPD.
참고문헌 (19)
- Mathers CD, "Projections of global mortality and burden of disease from 2002 to 2030", PLoS Med, 3, pp.e442~ (2006)
- Sullivan SD, "The economic burden of COPD", Chest, 117(2 Suppl), pp.5S~9S (2000)
- Muneswarao J, "Global initiative for chronic obstructive lung disease(GOLD)2018 report : highlighting an incorrect information", Pulm Pharmacol Ther, 49, pp.10~ (2018)
- Salinas GD, "Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians", Int J Chron Obstruct Pulmon Dis, 6, pp.171~179 (2011)
- 정상미, "Evaluation of Appropriate Management of Chronic Obstructive Pulmonary Disease in Korea: Based on Health Insurance Review and Assessment Service (HIRA) Claims", Tuberculosis and Respiratory Diseases, 80(3), pp.241~246 (2017), 대한결핵및호흡기학회
- Vandevoorde J, "FEV1", FEV6 and FEV6 as an alternative for FEV1, Chest, pp.2005, 127[DOI]
- Swanney MP, "FEV(6)is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction", Am J Respir Crit Care Med, 162(3 Pt 1), pp.917~919 (2000)
- Enright RL, "The FEV1", FEV6 predicts lung function decline in adult smokers, 2002, pp.96, 444~449
- Kim JK, "Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry", Medicine (Baltimore), 95, pp.e5683~ (2016)
- Van den Bemt L, "Diagnostic accuracy of pre-bronchodilator FEV1", FEV6 from microspirometry to detect airflow obstruction in primary care : a randomised cross-sectional study, 2014, pp.24, 14033~
- Kjeldgaard P, "Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?", Int J Chron Obstruct Pulmon Dis, 12, pp.2323~2331 (2017)
- "VITALOGRAPH 4000 series: respiratory monitors & screening devices" (2020)[URL]
- Qaseem A, "Diagnosis and management of stable chronic obstructive pulmonary disease : a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society", Ann Intern Med, 155, pp.179~191 (2011)
- Yoo KH, "Prevalence of chronic obstructive pulmonary disease in Korea : the fourth Korean National Health and Nutrition Examination Survey, 2008", Respirology, 16, pp.659~665 (2011)
- 박명재, "우리나라 일차 진료의사의 만성폐쇄성폐질환(COPD) 진료실태조사", Tuberculosis and Respiratory Diseases, 64(2), pp.109~124 (2008), 대한결핵및호흡기학회
- Chung KS, "Cut-off value of FEV1", FEV6 as a surrogate for FEV1, Int J Chron Obstruct Pulmon Dis, pp.2016, 11[DOI]
- Singh D, "Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease : the GOLD science committee report 2019", Eur Respir J, 53, pp.1900164~ (2019)
- Aaron SD, "Diagnostic instability and reversals of chronic obstructive pulmonary disease diagnosis in individuals with mild to moderate airflow obstruction", Am J Respir Crit Care Med, 196, pp.306~314 (2017)
- GBD 2013 Mortality and Causes of Death Collaborators, "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 385, pp.117~171 (2015)